PRIME Cohort Studies

The cohort studies are treatment cohorts which assessed the clinical, social and economic outcomes of patients who have received a diagnosis of depression, alcohol use disorder (AUD), psychosis or epilepsy. In some countries a control group (patients who screen positive for a disorder but were undiagnosed by a clinician) were also followed up. Key research themes included social, health and economic outcomes, equity of access, and stigma, discrimination, adherence and retention in care. After the baseline data collection, patients were followed-up after 3 or 6 months (mid-line visit), and again 12 months after the baseline (end-line visit). A detailed description of the cohort methods has been published in BMC Psychiatry (see link on references).Below is a brief overview of the design, recruitment and data collection methods. If you wish to access the cohort dataset, please complete an expression of interest form (see link on references).